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Abstract
Stochastic fluctuations in gene expression give rise to cell-to-cell variability in protein levels which can potentially cause
variability in cellular phenotype. For TRAIL (TNF-related apoptosis-inducing ligand) variability manifests itself as dramatic
differences in the time between ligand exposure and the sudden activation of the effector caspases that kill cells. However,
the contribution of individual proteins to phenotypic variability has not been explored in detail. In this paper we use
feature-based sensitivity analysis as a means to estimate the impact of variation in key apoptosis regulators on variability in
the dynamics of cell death. We use Monte Carlo sampling from measured protein concentration distributions in
combination with a previously validated ordinary differential equation model of apoptosis to simulate the dynamics of
receptor-mediated apoptosis. We find that variation in the concentrations of some proteins matters much more than
variation in others and that precisely which proteins matter depends both on the concentrations of other proteins and on
whether correlations in protein levels are taken into account. A prediction from simulation that we confirm experimentally is
that variability in fate is sensitive to even small increases in the levels of Bcl-2. We also show that sensitivity to Bcl-2 levels is
itself sensitive to the levels of interacting proteins. The contextual dependency is implicit in the mathematical formulation of
sensitivity, but our data show that it is also important for biologically relevant parameter values. Our work provides a
conceptual and practical means to study and understand the impact of cell-to-cell variability in protein expression levels on
cell fate using deterministic models and sampling from parameter distributions.
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Introduction
Variability in the responses of tumor cells to biological stimuli is
often ascribed to genetic differences. However, it has become
increasingly clear that even genetically identical cells growing in a
homogenous environment respond differently to ligands, drugs, or
other stimuli. Non-genetic variability at the single-cell level has
been demonstrated in the activation of immune responses
[1,2,3,4], viral infectivity [5,6,7], developmental fate [8,9,10,11],
antibiotic resistance [12], and sensitivity to therapeutic drugs
[13,14,15]. Such variability can arise from relatively long-lasting
‘‘epigenetic’’ changes that have their origins in stable and heritable
programs of gene expression [16] and can be sensitive to histone
deactylase inhibitors that disrupt the histone code [14]. Substantial
phenotypic variability also arises from fluctuation in the levels or
activities of proteins (or other biomolecules) that control cell fate;
the current paper is concerned with this type of variability.
Two sources of non-genetic variability can be distinguished.
The first, often called ‘‘intrinsic noise’’, arises when the copy
number of molecules participating in a reaction under study is
sufficiently small that probabilistic fluctuations in protein-protein
interactions or biochemical reactions have observable effects [17].
Such processes are modeled using stochastic methods. The second
source of variation, often called ‘‘extrinsic noise,’’ arises when
protein concentrations in individual cells are high enough that
single-cell reaction trajectories are well approximated by mass-
action kinetics, but ‘‘external’’ or pre-existing cell-to-cell differ-
ences in the activities or concentrations of biomolecules have an
effect [17]. With either intrinsic or extrinsic noise, phenotypes vary
from one cell to the next but the processes that cause cells to differ
are either part of or external to the biological process under study.
When clonal cell populations are treated with TNF-related
apoptosis inducing ligand (TRAIL), their response is dramatically
different from cell to cell: some cells die with 45 min, some die
after as long as 12 hr, and some do not die at all [15,18]. We have
investigated the contributions of intrinsic and extrinsic noise to this
variability by studying sister cells [15]. Were cell-to-cell variability
to arise predominantly from intrinsic noise, we would expect sister
cells to be no more correlated phenotypically than two cells
selected at random from a population: intrinsic noise cannot be
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time and probability of TRAIL-induced cell death are highly
correlated in newly born sister-cell pairs. The correlation in time of
death between sister cells decays on a time scale of hours to days so
that older sister cells are ultimately no more similar to each other
than are pairs of cells selected at random from the population.
Were cell-to-cell variability in phenotype to arise from differences
in protein levels or activities, we would expect phenotypes to be
transiently heritable (as observed with TRAIL) because binomial
partitioning of cellular contents at division causes sisters to inherit
similar numbers of high abundance biomolecules [19,20].
Subsequent decorrelation in protein levels, and thus in time and
probability of death, is also expected because fluctuations in
protein synthesis and degradation (processes that exhibit signifi-
cant intrinsic noise [6]) have an increasing impact as time
progresses. The time required for sister cells to diverge and
recapitulate the steady state distribution is known as the ‘‘remixing
time’’. Factors that determine remixing times are not fully
understood [8,9,21] but translation rates are one contributor.
Because cell-to-cell variability in responses to TRAIL can be
ascribed primarily to differences in protein concentrations existing
at the time of ligand addition and not to intrinsic noise in signal
transduction reactions, deterministic mass-action modeling is
appropriate [15]. Indeed, attempts to reproduce observed
variability in cell death dynamics using conventional stochastic
simulations have not succeeded, probably because proteins that
regulate apoptosis are abundant [22].
TRAIL-mediated apoptosis involves binding of TRAIL ligand
to transmembrane DR4/5 receptors and consequent activation of
effector caspases. To simulate these processes we have developed a
series of mass-action models based on networks of ordinary
differential equations (ODEs; referred to as extrinsic apoptosis
reaction models, or EARMs) that have been validated in single-cell
studies using small molecule drugs, pathway-wide RNAi, and
protein overexpression [18]. EARM describes the dynamics of
death in single cells with good accuracy, particularly when cells are
exposed to low-dose cycloheximide that blocks de novo protein
synthesis (from the perspective of modeling, use of cycloheximide
obviates the need to model TRAIL-induced transcription and
translation and reduces the number of model parameters). Upon
TRAIL stimulation, death-inducing signaling complexes (DISCs)
assemble on the cytoplasmic tails of TRAIL-bound DR4/DR5
receptors, activating initiator pro-caspases-8 and -10 (hereafter
referred to as caspase-8 or C8 for simplicity, Figure 1). Active
caspase-8 directly cleaves effector pro-caspases-3 and -7 (hereafter
simplified to caspase-3 or C3) but in most cell types, including
those studied here, caspase-3 activity is held in check by XIAP
until mitochondrial outer membrane permeabilization (MOMP)
takes place. MOMP is controlled by members of the Bcl-2-family
of proteins, which includes both positive and negative regulators.
Active caspase-8 cleaves Bid into tBid which then induces a
conformational change in Bax. Active Bax translocates to the
mitochondria, where it (or its homolog Bak) multimerizes and
form transmembrane pores. Pore assembly is antagonized by anti-
apoptotic Bcl-2 proteins present in the cytosol and outer
mitochondrial membrane. Only when levels of active Bax/Bak
exceed those of inhibitory Bcl-2 proteins does pore formation
begin and MOMP take place, releasing cytochrome c and Smac
into the cytosol in a sudden, all-or-none process. Cytochrome c
forms an apoptosome complex that also contains Apaf-1 and
activates caspase-9, thereby creating an additional factor capable
of processing pro-caspase-3. Smac binds to XIAP, which prevents
XIAP from associating with active caspase-3, freeing caspase-3 so
it can cleave substrates such as the inhibitor of caspase-activated
DNase (ICAD) and poly (ADP-ribose) polymerase (PARP), and
thereby promote fragmentation of the genome and proteome.
The current work aims to evaluate the impact of changes in the
concentrations of apoptosis regulators on the dynamics of effector
caspase activation in cells treated with TRAIL, particularly for
changes that arise from natural variation in protein levels from one
cell to the next. Because we observe such variation to be constant
across a continuously growing cell population (that is, to be quasi-
static) time-invariant distributions of initial protein concentrations
Figure 1. The TRAIL-induced signaling network. (A) Schematic
diagram of the TRAIL-induced cell death signaling network including
live-cell imaging reporters for MOMP, the inter-membrane space
reporter protein (IMS-RP), and for initiator or effector caspase activity
(IC-RP or EC-RP, respectively). The features tPARP, fPARP, and tswitch can all
be evaluated based on EC-RP dynamics and tMOMP can be measured in
live cells using IMS-RP. IC-RP enables measurement of the threshold of
cleaved initiator caspase substrate required for MOMP and of an initial
rate of caspase activity (kIC). See also Figure 2 and Table Box 1 for
description of how reporter dynamics were modeled and for precise
definitions of features.
doi:10.1371/journal.pcbi.1002482.g001
Author Summary
Variability among members of a clonal cell population is
increasingly recognized as a near-universal characteristic of
prokaryotic and eukaryotic cells. Variability can arise from
random fluctuations in the biochemical reactions that
control gene transcription, protein synthesis or signal
transduction networks. For variability in receptor-mediated
signaling responses (in the current work, those activated
by the death-inducing ligand TRAIL), we can often
distinguish between the influence of stochastic processes
that occur prior to ligand exposure and those that occur
subsequently. One manifestation of prior variability is cell-
to-cell differences in protein concentrations, and this
paper uses a combination of modeling and experimenta-
tion to ask how these differences impact variability in
phenotype, specifically with respect to the timing and
probability of cell death. We find that fluctuations in
multiple proteins contribute jointly to phenotypic variabil-
ity, that the contributions of specific proteins to pheno-
typic variability are highly sensitive to the concentrations
of other proteins, and that correlations in protein levels
(detectable experimentally) also have a measurable impact
on phenotype. Our work provides insight into the
regulation of apoptosis and also represents a general
approach for understanding cell-to-cell variability in signal
transduction pathways.
Modeling Cell-to-Cell Variability
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concentration distributions in asynchronous cell populations using
flow cytometry and microscopy and, when suitable reagents were
available we also measured correlations in the concentrations of
different proteins. Variability in the dynamics of apoptosis was
then simulated by sampling from these distributions. In principle,
we expect variation in the levels of some proteins to matter more
than variation in others, and we show that this is indeed the case.
We explore the impact of correlations in the levels of one or more
model species and also ask how many species must be measured to
accurately predict phenotype. Finally, we show that the pheno-
typic consequences of variation in particular proteins are affected
by changes in the concentrations other apoptotic regulators,
demonstrating contextual dependency in the contributions made
by regulatory molecules to the timing and probability of cell death.
Results
Feature-based sensitivity analysis of cell death dynamics
Cell death is represented in EARM by caspase-mediated
proteolysis of PARP to generate cleaved PARP (cPARP): previous
studies have shown that HeLa cells are inviable when cPARP
exceeds ,10% of initial PARP levels ([cPARP].0.10*[PARP]0)
[23]. Under normal circumstances, cleavage of effector caspase
substrates constitutes a ‘‘snap-action’’ switch that is well described
by a sigmoidal Boltzmann trajectory in which an extended delay is
followed by sudden and complete PARP proteolysis [18,24]. The
delay time is long (45 min to 12 hr), varies from cell to cell, and
increases as the dose of TRAIL decreases. In contrast, the rate of
PARP cleavage is rapid once begun, and dose-invariant (the time
between the first detectable cleavage of PARP and its completion
is typically 20–25 min). However, RNAi-mediated depletion of
regulatory proteins such as XIAP or treatment of cells with
proteasome inhibitors such as MG132 changes the dynamics so
that PARP is cleaved more slowly and may not go to completion.
We have previously argued that these qualitative changes create a
pathological state in which caspase-activated DNase is active,
genomic DNA damaged, but some damaged cells do not die
[18,23]. Such cells have been proposed to play a role in tumor
initiation [25,26,27,28]. Thus there is a fundamental difference
between natural variation in the timing of apoptosis and the
breakdown associated with slow and incomplete execution of the
apoptosis program.
The impact of changes in the initial protein concentrations or
other parameters on model output is determined using sensitivity
analysis. For extrinsic apoptosis we can distinguish between
normal and pathological behaviors using four features of cPARP
and cytosolic Smac trajectories: 1) tPARP, the time between ligand
exposure and 50% PARP cleavage (i.e. time of cell death), 2)
tMOMP, the time between ligand exposure and MOMP (defined
experimentally as the first image in which a fluorescent MOMP
reporter appears diffuse in the cytoplasm and in the model as the
Box 1. Feature-based sensitivity
Parameters in mass-action biochemical models include initial
protein concentrations, and kinetic parameters such as
association, dissociation, and catalytic rate constants, Hill
coefficients etc. The impact of changes in parameter values
on model outputs, typically dynamical variables such as the
concentrations or activities of proteins over time, is
calculated using sensitivity analysis. In EARM, the dynamical
variable reporting on MOMP is the level of cytosolic Smac
and the variable reporting on effector caspase activity is the
level of cleaved PARP (cPARP) (Figure 2A). The conventional
sensitivities of these variables are the normalized changes at
a particular point in time arising from an infinitesimal change
in a parameter value. Often, these partial derivatives are
integrated over time (Figure 2B, gray areas).
If we consider the impact of RNAi and naturally occurring
cell-to-cell variability on the trajectories of cytosolic Smac or
cPARP we realize that conventional sensitivity values are not
particularly informative: variation in the timing of cPARP
accumulation is normal (Figure 2B, top panel) while
incomplete or abnormally slow PARP cleavage is patholog-
ical (Figure 2B, center and bottom panels respectively), but
the time integrated sensitivities for all three scenarios are
similar (approximated by the gray areas between the curves).
Physiological and pathological changes in cPARP dynamics
can be discriminated using features of the trajectories such as
the time at which PARP is 50% cleaved (tPARP), the time
required for cPARP to go from 10% to 90% cleaved (tswitch)o r
its final fraction relative to [PARP]0 (fPARP) (Figure 2A;
mathematical definitions in Table 1). As shown in this paper,
feature-based sensitivities are more effective than conven-
tional sensitivity in analyzing apoptotic regulators because
they report on biologically meaningful variation. The
concept of feature-based sensitivity can also be reformulated
for different types of trajectories in any dynamical system
and these sensitivities can be computed locally (e.g. Figure
S1) or as part of global sensitivity analysis (see for example
algorithms in ref. [42,43,44] and reviewed in ref. [45]).
The sensitivity of time-based features such as tPARP or tMOMP is
approximated by:
Lt
Lk
%{
Ly
Lk
       
t~t
Ly
Lt
       
t~t
   {1
ð1Þ
where k is a model parameter, t represents the time-based
feature of interest (tPARP, tMOMP) and y is the dynamical
variable that governs the feature (cPARP and cytosolic Smac,
for tPARP and tMOMP respectively; the derivation of Equation 1
is described in Text S2). Thus, feature sensitivity is
approximately equal to the conventional sensitivity
{
Ly
Lk
       
t~t
divided by the slope of the trajectory
Ly
Lt
       
t~t
evaluated at the appropriate time point for the feature (t~t;
e.g. when PARP is 50% cleaved for tPARP or when Smac is 50%
cytosolic for tMOMP). Equation 1 also has an appealing
geometric interpretation when we graph y as a function of
time, as we illustrate in Text S2. Equation 1 is valid in the
ideal case where MOMP and PARP cleavage are observed in
every simulation, however when simulations are performed
for finite time intervals (and not all cells die in certain regions
of k) the formula breaks down (Figure S1 in Text S1). A
practical alternative is to use numerical methods for
computing tMOMP and tPARP (see main text and Figures 3A
and S2, S3, S4).
Both tswitch and fPARP can be defined by expressions based on
evaluating the cPARP dynamic variable at specific time
points, and therefore exact analytical expressions can be
derived for their sensitivities to changes in parameter values;
these are listed in Table 1.
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compartment), 3) tswitch, the time between the start and finish of
PARP cleavage (a measure of the rate of PARP cleavage), and 4)
fPARP, the fraction of PARP cleaved at the end of the simulation or
experiment (a measure of the completeness of apoptosis). In
unperturbed HeLa cells exposed to 50 ng/ml TRAIL and 2.5 mg/
ml cycloheximide, tPARP and tMOMP varied from 2–6 hr, tPARP
occurred ,10 min after tMOMP (at a single cell level), tswitch was
,25 min, and fPARP was ,1.0 [23,29].
The sensitivities of these features to changes in parameter values
are related to but distinct from conventional sensitivities.
Analytical expressions for feature sensitivities are described in
Box 1 but the calculations in this paper actually involve numerical
methods that account for complex non-local effects (see Text S2
and Box 2 for further details). In the numerical approach,
sensitivities are calculated by Monte Carlo sampling of initial
protein concentrations thereby repeatedly evaluating the local
slope of the response curve for a feature. We evaluated feature
sensitivities with respect to 16 non-zero initial protein concentra-
tions individually by simulating PARP cleavage and Smac
translocation dynamics in cells exposed to 50 ng/ml TRAIL
while sampling uniformly in the exponent over a range of 10
2–10
7
proteins per cell (all other parameters remained at their nominal
values). This range of concentrations reflects the range of possible
concentrations for proteins in a mammalian cell [30,31]; for
apoptotic regulators it is a reasonable approximation to the
concentration range achieved by protein overexpression or RNAi-
mediated protein depletion. EARM has been validated using such
methods and it performs well under these conditions [15,23,29],
although most analysis has been performed for protein levels
present in unperturbed HeLa cells.
The sensitivity of model features to changes in protein levels
broadly conformed to expectation: for tMOMP, higher levels of pro-
apoptotic proteins lying upstream of pore formation decreased its
value (Receptor, caspase-8, Bid, and Bax; Figure 3A, green curves
show responses, blue curves show sensitivities) whereas higher
levels of upstream anti-apoptotic proteins (FLIP, Bar, Mcl-1, Bcl-2;
Figure 3A) increased its value. In contrast, changes in the levels of
downstream proteins had little effect (e.g. caspase-3, caspase-9,
Apaf1; Figure 3A, bottom row). The sensitivities of other features
are shown in Figures S2, S3, S4 in Text S1. They reveal that
different features exhibit different sensitivity with respect to protein
initial concentrations. These sensitivities varied considerably in
magnitude with position in parameter space: over some concen-
tration ranges, small changes in the levels of proteins such as FLIP,
Mcl-1 or Bcl-2 had a large impact on model output but over other
ranges the impact of small changes was minimal (Figure 3A). For
example, when [Bcl-2] lay between 10
4 and 10
5 molecules per cell,
tMOMP changed rapidly whereas with [Bcl-2] between 10
2 and 10
4
molecules per cell, tMOMP changed very little. Because sensitivity is
a local property of a model, this result is expected from a
mathematical perspective but is often overlooked from a biological
perspective.
To estimate mean concentrations of apoptotic regulators in
HeLa cells, we used calibrated immunoblotting and recombinant
protein standards (Figure S5 in Text S1); to estimate variation in
Box 2. Variance in system behavior relates to variance and co-variance in parameter values
Although it is conventional to emphasize individual deter-
minants of cellular phenotype, natural variation in TRAIL-
mediated cell death is regulated by multiple factors in
surprisingly subtle ways ([15,23,29,34]; and this work). We
can understand why this is true by deriving an approximate
relationship between the variance of a feature and changes
in the level of a particular parameter; in the current work we
are particularly concerned with the impact of naturally
occurring fluctuations in initial protein concentrations.
Variance of feature q (s2
q) is approximately:
s2
q&
X N
a,b~1
Lq
Lln c0
a
   Ma,b
Lq
Lln c0
b
   ð2Þ
where the indices a, b refer to pairs of N concentration
parameters, c0
a and c0
b are their initial concentrations (in log
units) and Ma,b is the covariance matrix of concentrations
(see Supplemental Text S1 for the derivation). If protein
levels are assumed to be uncorrelated then off-diagonal
terms are zero and the entire expression is reduced to a sum
of squared terms over all proteins having non-zero initial
concentrations:
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From Equation 3 we see that variances in protein concen-
trations contribute only positively and additively to variances
in features. A caveat to Equations 2 and 3 is that sensitivities
are local and the approximations do not account for changes
in sensitivity as parameters vary; these effects (which can be
large in some cases) are most easily estimated with
numerical methods such as Monte Carlo sampling of
parameter distributions (as in Figure 3). Nevertheless,
Equation 2 would provide an extensible approach to
approximate the impact of covariance of sets of three or
more parameters.
We can also use Equation 2 to understand the possible
phenotypic consequences of measured or postulated
correlations in protein concentrations. The right-hand side
of Equation 2 is a product of three terms comprising two
feature sensitivities and co-variation between two concen-
trations. Sensitivities can be positive or negative (‘‘anti-
apoptotic’’ or ‘‘pro-apoptotic’’ if considering tPARP or tMOMP,
for example) and co-variation between two protein concen-
trations can also be positive or negative, although positive
co-variation is expected [35] in the absence of a specific
regulatory mechanism to enforce negative co-variation (e.g.
by a ubiquitin ligase and its target). Considering the sign of
individual terms, we arrive at four scenarios (Table 2). In
scenario 1, in which sensitivities to variation in two
parameters have opposite signs (one positive and one
negative) and covariance is positive, variation in features
controlled by the parameters will decrease, precisely what
we observe for XIAP and Smac (Figure 5B). Conversely,
positive covariance for two parameters having the same
influence on a feature (either negative or positive) will
increase variance in the feature (scenario 2), which is what is
observed for the pro-apoptotic proteins Apaf1 and Smac
(Figure 5B). Scenarios 3 and 4 are the converse, and pertain
to situations where covariance is negative.
Modeling Cell-to-Cell Variability
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([15]; Figures S6, S7, S8 in Text S1). The selectivity of antibodies
was validated using siRNA-mediated protein knockdown and/or
protein over-expression (Figure S7 in Text S1). Bcl-2, for which
good antibodies are available, was assayed using both immuno-
fluorescence microscopy and flow cytometry and we observed
excellent agreement between the two types of measurement
(Figure 3B). Both measurements rely on immunodetection and we
wanted to exclude the possibility that variability in antibody-
antigen binding might have a significant impact on the measured
distributions. We therefore transfected cells with a construct
expressing GFP-Bcl-2 and quantified the intensities of GFP and of
anti-Bcl-2 immunofluorescence in the same cells (Figure 3C). In a
two-dimensional scatter plot of these measurements, variation
along the diagonal represents real cell-to-cell differences in Bcl-2
concentration whereas off-diagonal variation represents differenc-
es between antibody-based and GFP-based estimates of Bcl-2
abundance. Off-diagonal variation can arise from antibody
binding, instrument error, the presence of some immature and
non-fluorescent GFP-Bcl-2 molecules, or variability in levels of
endogenous Bcl-2. Off-diagonal variation therefore represents an
upper-bound estimate of measurement error arising from antibody
binding and detection. We observed that off-diagonal variation
was significantly smaller than natural cell-to-cell variation in
endogenous Bcl-2 levels, suggesting that estimates of variability in
Bcl-2 levels do indeed reflect real differences in protein abundance
from cell to cell (Figure 3D).
Across a set of five proteins for which we could demonstrate
antibody selectivity (only a subset of commercially available
antibodies are suitable), measured distributions of protein
abundance were unimodal and long-tailed as has been observed
previously in mammalian cells [21,32]. All were well fit by log-
normal distributions, although we cannot exclude the possibility
that gamma distributions or other long-tailed distributions are also
appropriate representations of the data (Figure S8 in Text S1).
The coefficients of variation (CV; standard deviation divided by
mean) were between 0.43 and 0.47 but some of this variation is
expected to arise from differences in cell size. We therefore
selected cells with similar forward and side scatter measurements,
which reduced CVs to 0.2860.02 to 0.3060.03 depending on the
protein. Given the relatively narrow range of values for the CV, it
seemed reasonable to assume similar variance for those proteins
we could not assay experimentally. We therefore set CV=0.25 for
proteins whose distributions were assumed rather than measured
(to err on the conservative side). In Figure 3A we relate the
sensitivity of tMOMP to endogenous protein concentrations in HeLa
cells by positioning double vertical bars at the 5
th and 95
th
percentiles of the protein concentration distributions (see also
Figures S1, S2, S3, S4 for other features). In general, data and
simulations predicted HeLa cells to be more sensitive to increases
than to decreases in the levels of anti-apoptotic proteins across the
endogenous range; the opposite is true for pro-apoptotic proteins.
The endogenous distributions of Bcl-2 and Bax were particularly
interesting because they suggested that HeLa cells lie close to a
region of parameter space in which small changes are expected to
have a large impact on tMOMP, a finding we analyze in greater
detail below.
Variability in some but not all protein concentrations
changes death dynamics
To compute the impact of natural variation in protein levels on
tMOMP, tPARP, fPARP, and tswitch, we used Monte Carlo methods that
sample from log-normal distributions of initial protein concentra-
tions (based on measured or assumed values for the mean and
Figure 2. Feature-based description and sensitivity of apopto-
sis dynamics. (A) Plot showing the simulated time courses of cleaved
PARP (blue; an effector caspase substrate), total cytosolic Smac (green)
and total cleaved Bid (tBid, yellow; an initiator caspase substrate).
Cleaved PARP corresponds to model species 23. Total cytosolic Smac is
the sum of Smac_r (species 47), Smac (species 45) and Smac:XIAP
(species 57). Total cleaved Bid is the sum of tBid (species 26), tBid:Bax
(species 28), and tBid:Mcl1 (species 30). The four model features under
investigation are indicated (tMOMP, tPARP, fPARP, and tswitch), as well as two
features used to classify proteins in Figures 4 and 7 (the initiator
caspase rate, kIC, and threshold). (B) Schematic representations of three
classes of changes in the cPARP trajectory and the corresponding time-
integrated value of the parameter sensitivity (gray). Changes that are
quantitatively similar in terms of conventional sensitivity are distinct by
feature sensitivity. The same qualitative distinctions apply to sensitiv-
ities calculated in the limit of an infinitesimal change in parameter
values. Therefore the curves in panel B are related to feature
sensitivities (and to Equation 1) as shown by the expressions on the
right.
doi:10.1371/journal.pcbi.1002482.g002
Modeling Cell-to-Cell Variability
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features were unimodal regardless of whether we varied each
protein concentration individually (with all others fixed at their
nominal values; Table S2 in Text S3) or varied all proteins
simultaneously (while sampling independently; Figure 4B–E). In
no case did natural variation in the concentration of a single
protein generate as much variation in tMOMP as simultaneous
variation in all proteins (CV=0.11 for tMOMP when Bax alone was
varied as compared to CV=0.24 for tMOMP when all proteins were
varied independently). Results for tPARP were similar except that
variation in XIAP levels (and to a lesser extent, variation in other
proteins downstream of MOMP) also had an impact (Figure 5C).
This is expected since XIAP is a direct negative regulator of
caspase-3, and caspase-3 is the enzyme that cleaves PARP. From
these data we conclude that experimentally observed variation in
the time of MOMP or PARP cleavage is controlled in a multi-
factorial manner and that total phenotypic variation cannot be
explained by measured variation in any single protein concentra-
tion. A mathematical explanation of this effect is presented in Box
2.
In contrast, variability in fPARP was dominated by variability in
the levels of XIAP, and the impact of varying XIAP alone was
almost as great as that of varying all proteins simultaneously (Box
2, Equation 3 shows that it cannot be greater; Figure 5E). The
situation was similar for tswitch, except that factors downstream of
MOMP also had an effect on this feature. These observations help
to explain previous RNAi and over-expression data showing that
forced changes in the levels of proteins that impact fPARP also affect
tswitch, and that both features are particularly sensitive to changes in
the levels or activity of XIAP [18,23,33]. Indeed, the most potent
way to reduce the efficiency of apoptosis experimentally in HeLa
cells (i.e. increase tswitch or reduce fPARP) and generate ‘‘half-dead’’
cells, appears to be to interfere with the levels or activity of XIAP
[23]; the same is true in HCT116 human colon carcinoma cells
[34]. Taken together, these results make the point that the
‘‘robustness’’ of a cell to variation in any single parameter is
strongly dependent on the feature being evaluated: tMOMP is robust
to variation in [XIAP] but tswitch and fPARP are particularly sensitive
to it. We find that virtually all of the proteins in the model are
determining factors (sensitive parameters) for at least one
physiologically important variable.
Impact of co-variance in protein levels
Correlation in the levels of regulatory proteins is expected to
alter the relationship between variability in protein concentration
and variability in phenotype (Box 2, Equation 2). Using two-color
flow cytometry, we measured correlations in the concentrations of
Bax, Bcl-2, Bid, caspase-3 and XIAP across all ten pairwise
combinations (suitable antibodies pairs were not available for other
regulatory proteins). Gating on forward and side scatter was used
to select for cells of similar size since positive correlation is
expected simply based on cell volume. With stringent gating, we
observed positive linear correlation coefficients that ranged from
R,0.4 for caspase-3 and Bcl-2 to R,0.7 for Bax and Bcl-2
(Figure 5A–B). No negative correlations were observed, consistent
with results from bacteria showing that extrinsic noise is expected
Table 1. Mathematical definitions of features of the apoptosis process modeled in EARM and their analytical expressions for
parameter sensitivity.
Feature Analytical expression for feature sensitivity
tMOMP is t at which: total cytosolic Smac ½  ~
1
2
  Smacm ½  t~0 LtMOMP
L logk ðÞ
&{k  
L total cytosolic Smac ½ 
Lk
       
t~tMOMP
L total cytosolic Smac ½ 
Lt
       
t~tMOMP
tPARP is t at which: cPARP ½  ~
1
2
  PARP ½  t~0 LtPARP
L logk ðÞ
&{k  
L cPARP ½ 
Lk
       
t~tPARP
L cPARP ½ 
Lt
       
t~tPARP
fPARP:
cPARP ½  t~end
PARP ½  t~0
LfPARP
L logk ðÞ
~
k
PARP ½  t~0
 
L cPARP ½ 
Lk
       
t~end
tswitch:
d cPARP ½ 
dt
       
t~tPARP
 ! {1
Ltswitch
L logk ðÞ
~{k  
L
d cPARP ½ 
dt
  
Lk
               
t~tPARP
 
d dPARP ½ 
dt
       
t~tPARP
 ! {2
doi:10.1371/journal.pcbi.1002482.t001
Table 2. Impact of co-varying protein concentrations on variation in features.
Scenario Sensitivity of A, B
a Co-variation of A,B Impact on variance in feature
1 +,2 or 2,+ + 2
2 +,+ or 2,2 + +
3 +,2 or 2,+ 2 +
4 +,+ or 2,2 2 2
Notes:
a‘‘A’’ and ‘‘B’’ refer to two parameters for which a feature sensitivity has been computed.
doi:10.1371/journal.pcbi.1002482.t002
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PLoS Computational Biology | www.ploscompbiol.org 6 April 2012 | Volume 8 | Issue 4 | e1002482Figure 3. Sensitivity of tMOMP to changes in protein initial concentrations and measurements of protein variance and co-variance in
HeLa cells. (A) Scatter plots show the simulated relationship between initial protein concentration and tMOMP (green) or numerically calculated tMOMP
sensitivity (blue; tMOMP sensitivity is unitless and is calculated using finite-difference approximations of the derivatives, or slopes, of the green curves)
following TRAIL addition, for the indicated proteins. The initial concentration for the indicated protein was uniformly sampled in the exponent for
values between 10
2 to 10
7 proteins per cell while all other initial protein concentrations and rate constants were set at their default value. Vertical
bars represent the 5
th and 95
th percentiles of the measured (orange, see panel B–D and Table S2) or assumed (gray) distributions in endogenous
protein concentrations for untreated HeLa cells. Shaded regions in the plot for Bid show an example of concentration ranges that were attained
experimentally using RNAi knockdown and GFP-fusion protein overexpression [15,23,29]. (B) Overlays of endogenous Bcl-2 concentration
distributions in untreated HeLa cells as measured by flow cytometry (FACS, blue), or immunofluorescence (IF, green). The FACS data are well fit by a
log-normal distribution (Fit, red); a.u., arbitrary units. (C) Scatter plot of anti-Bcl-2 vs. GFP-Bcl-2 signal in GFP-Bcl-2-transfected HeLa cells measured by
2-color flow cytometry. (D) Histograms of the endogenous Bcl-2 concentration distribution in wildtype HeLa cells measured with an anti-Bcl-2
antibody (left) and of the off-diagonal noise distribution for the scatter plot in (B) (right). Both distributions are for mean-centered data to allow
comparison of variability; std is the standard deviation and IQR is the interquartile range.
doi:10.1371/journal.pcbi.1002482.g003
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specifically counter-regulated [35].
To determine the impact of correlation in protein expression on
model features we constructed a five-dimensional joint distribution
based on pair-wise measurements and performed Monte Carlo
sampling. Protein pairs whose co-variance is unknown were
assumed to be uncorrelated. Including the measured correlations
in initial protein concentrations reduced the predicted variability
in tPARP from a CV=0.23 to CV=0.19, a statistically significant
improvement in the match to experimental data (for which
CV=0.18; Figure 5C). We conclude that measured co-variation
in protein levels has a significant impact on variability in the
timing of death.
To investigate the impact of correlations in protein concentra-
tions in cases in which experimental data could not be collected,
we performed simulations considering each protein pair and
assuming either independent distributions or a single joint pairwise
distribution with R=0.7 (the highest correlation observed
experimentally; Figure 5B). All other proteins were sampled
independently from their respective log-normal distributions. tPARP
is the feature whose variance was affected by the greatest number
of parameters (Figure 4B–E) and we therefore focused on it. For
each pair of proteins in the model, we computed the ratio between
the variance in tPARP expected under assumptions of independence
or positive correlation (Figure 5D). In many cases effects were
relatively modest. The largest single difference involved the anti-
apoptotic XIAP protein and its pro-apoptotic binding partner
Smac whose assumed correlation reduced dispersion in tPARP two-
fold. This represents one example of a general phenomenon:
positive correlations in the concentrations of pairs of proteins
having opposing roles in apoptosis reduced the spread in death
times (Figure 5D, red shading; see Box 2 for further explanation).
Although correlations in protein levels had a modest impact on
variability in tPARP, it significantly altered the phenotypic
consequences of variation in individual proteins. This can be seen
by sampling from the experimentally determined joint distribu-
tions for Bax, Bcl-2, Bid, caspase-3 and XIAP (allowing all other
proteins to vary independently) and using the Pearson correlation
coefficient (R) to score the relationship between tPARP and the
initial concentration of each model species (Figure 5E and Figure
S9 in Text S1; similar results were obtained using Spearman’s rank
correlation coefficients, not shown). As expected, the R value for
pro-apoptotic proteins was negative and for anti-apoptotic proteins
it was positive (see also Figure S10 in Text S1 for an analysis
yielding similar results using the slope of the regression line).
Unexpectedly, Bcl-2 had virtually no correlation with tPARP
(R=0.002, Figure 5E) when concentrations were sampled from
joint distributions even though it was significantly correlated when
protein levels were assumed to be independent (R=0.37). To try
to explain this, we removed only the correlation between Bcl-2 and
Bax from the joint distribution and re-computed R values for tPARP.
This restored the impact of variance in Bcl-2 on tPARP,
demonstrating the contextual dependency of feature sensitivities
Figure 4. The impact of variability in protein initial concentra-
tions is feature-specific. (A) Histograms showing the distributions of
initial concentrations of Bcl-2 and XIAP used as inputs to the model
(left) and the model output distributions for tMOMP and tswitch (right).
Input distributions were generated by sampling 10,000 times from a
log-normal distribution parameterized with measured or assumed
mean and CV as listed in Table S2 in Text S3. Output distributions were
calculated from10
4 simulations where the initial concentration of the
indicated protein was sampled from the distributions shown on the left;
all others protein concentrations were set to their default value (Table
S2 in Text S3). (B–E) Bar graph showing the coefficients of variation (CV)
obtained for model output distributions of tMOMP (B), tPARP (C), fPARP (D),
and tswitch (E) from series of 10
4 simulations where the indicated protein
initial concentration is sampled from a log-normal distribution and all
other concentrations set to their default value (Table S2 in Text S3).
Proteins were classified as affecting the pre-MOMP rate of initiator
caspase activity (Rate; gray), the MOMP threshold (Threshold; purple) or
post-MOMP processes (Post-MOMP; green) based on their position in
the TRAIL-induced signaling network (Figure 1). In panels B–E, the black
bar (‘‘All’’) indicates the variability observed in a series of 10
4
simulations where all non-zero initial conditions were independently
sampled from log-normal protein distributions using the measured CV
where available or else CV=0.25 (as listed in Table S2 in Text S3).
doi:10.1371/journal.pcbi.1002482.g004
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PLoS Computational Biology | www.ploscompbiol.org 8 April 2012 | Volume 8 | Issue 4 | e1002482Figure 5. Correlations in protein levels affect the distribution of death times and the rank ordering of the most sensitive species. (A)
Scatter plots showing joint measurements of the levels of pairs of proteins in a population of HeLa cells by flow cytometry (least correlated pair, Bcl-2
and caspase-3 (C3), left; most correlated pair, Bcl-2 and Bax, right). (B) Bar graph showing the measured Pearson correlation coefficients (calculated by
linear regression) in the level of ten protein pairs. Error bars show the standard error of the mean. For all protein pairs, measurements were on cells
that were size-selected by stringent gating for forward and side scatter. (C) Bar graph of the CVs of tMOMP distributions measured by monitoring IMS-
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PLoS Computational Biology | www.ploscompbiol.org 9 April 2012 | Volume 8 | Issue 4 | e1002482(Figure 5E). At the mechanistic level, this result can be explained
by the fact that cells that have higher Bcl-2 levels (which should
cause them to die later, on average) also have more Bax (causing
them to die earlier, on average) because of positive correlation
between Bcl-2 and Bax concentrations. Thus, the correlation
between Bax and Bcl-2 dampens the variability in the [Bcl-
2]0:[Bax]0 ratio and masks the impact of Bcl-2 on tPARP. More
generally, correlations in protein concentrations can substantially
alter individual parameter sensitivities and such effects could be
strong enough to alter apparent mechanistic relationships between
proteins and phenotypes. Conceivably, these effects could also be
sufficient to mask the impact of forced changes in protein
expression induced by RNAi or overexpression.
Accurate prediction of time-to-death requires knowledge
of many protein levels
To determine the practical consequences of multi-factorial
control over tPARP, we asked how many measurements are required
to accurately predict time of death in a single cell. We performed
10
5 simulations of PARP cleavage in cells treated with 50 ng/ml
TRAIL and low-dose cycloheximide assuming Bax, Bcl-2, Bid,
caspase-3 and XIAP concentrations to co-vary and all other
proteins to vary independently. We modeled the process of
measuring one to eight proteins at a single-cell level assuming
experimental error of 612.5% and then computed how accurately
tMOMP could be determined. In actual microscopy experiments
tMOMP is typically sampled at 3 min intervals, resulting in a mean
squared error (MSE) of ,0.03. When we assumed knowledge only
of [Bid]0, the MSE in predicting tMOMP was 0.26, a poor estimate
given experimental error (reflected in the scatter of points around
the trend line in Figure 6A, left). Next, we prioritized measurements
by ranking them based on their contributions to variation in tPARP
(as judged by CV or R
2 values with respect to tPARP as shown in
Figures 4C and 5E) or to variation in tMOMP (as judged by R
2 values
with respect to tMOMP, as shown in Figure S10 in Text S1). We
observed that ability to predict tMOMP increased progressively
(Figure 6B and Figure S11 in Text S1) and that knowledge of the
sevenoreight mostsensitiveproteinconcentrationswasnecessaryto
achieve an MSE approaching experimental error (i.e. 0.03;
Figure 6A–B). In contrast, selecting proteins for measurement at
random from the full set of 16 species having non-zero initial
concentrations was ineffective in reducing the MSE. We conclude
that accurate prediction of time of death from initial protein
concentrations requires data on many proteins concentrations even
in the best case. Single-cell measurement of 30 or more protein
levels is now possible by mass cytometry [36], but these
measurements destroy cells and it is therefore impossible to use
the method to link multiplex measurement of protein concentration
to events, such as cell death, that occur many hours later. In this
RP translocation via time-lapse microscopy in HeLa cells treated with 50 ng/ml TRAIL with 2.5 mg/ml cycloheximide (green) or obtained from 10
4
simulations using independent sampling of all initial conditions (independent, blue), or sampling from the experimentally determined joint
distributions for Bax, Bcl-2, Bid, caspase-3 and XIAP (allowing all other proteins to vary independently; correlated, brown). Error bars represent
standard deviations obtained by bootstrapping (n=1000). Sampling for joint distributions reduced the predicted variability in tPARP from a CV=0.23
to CV=0.19, a statistically significant improvement in the match to experimental data: an Ansari-Bradley test for equal variability on median-corrected
data yielded p=0.006 for experimental data vs. independent sampling simulation, and p=0.137 for experimental data vs. sampling with correlated
distributions, rejecting the equal variance hypothesis only for data vs. independent sampling. (D) Heat map showing the effect of pairwise
correlations on tPARP variability. Above the diagonal (gray), color indicates the ratio of the CV of tPARP for 10
4 simulations with sampling from
correlated vs. independent distributions for the indicated pair (all other proteins were sampled independently from log-normal distributions
parameterized as in Table S2 in Text S3). Below the diagonal, the most significant p-value from a two-sample Kolmogov-Smirnov test is indicated in
green (p=0.04). (E) Bar graph of the Pearson correlation coefficients (R-values) of tPARP with the indicated protein initial concentration for simulations
sampling from fully independent distributions (blue), from joint distribution for Bax, Bcl-2, Bid, caspase-3 and XIAP (brown), or from a joint
distribution for the same five proteins where the Bcl-2-Bax correlation was set to zero (yellow bar). Scatter plots of tPARP as a function of initial protein
levels for the same simulation sets are presented in Figure S9 in Text S1.
doi:10.1371/journal.pcbi.1002482.g005
Figure 6. Predictability of death time is improved by knowl-
edge of key protein concentrations. (A) Scatter plot of predicted
tMOMP as a function of Bid initial concentration when no other initial
protein concentrations are known (left) or when the initial concentra-
tions of the next seven most influential proteins as ranked by R
2 of
tMOMP are also known with precision within 612.5% (right). Simulations
shown were selected from a series of 10
5 simulations sampling from a
joint distribution for Bax, Bcl-2, Bid, caspase-3 and XIAP (as measured)
and independently for all other proteins with non-zero initial
concentration. To mimic knowledge of a protein concentration,
simulations were randomly selected from those with an initial
concentration of mean value 612.5% for this protein. Black points
represent the predicted death times given perfect knowledge of the
concentrations of all model species. MSE is the mean squared error
relative to perfect knowledge (black points). (B) Graph of the mean
squared error in tMOMP (relative to perfect knowledge, black points in
(A)) as a function of the number of proteins whose concentration is
‘‘known’’; values are the averages from different runs and error bars
represent the standard deviations (n=10). ‘‘Known’’ proteins were
added either randomly (blue), by high-to-low R2 for tMOMP (gray; Figure
S10) or tPARP (yellow; Figure 5E), or by high-to-low CV for tPARP (brown;
Figure 4C).
doi:10.1371/journal.pcbi.1002482.g006
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single cell is not yet achievable experimentally, even though
determining distributions of death times is straightforward.
Bcl-2 over-expression shifts cells to a region of variable
cell fate where Bax levels become the primary
determinant of fate
HeLa cells are predicted to be highly sensitive to even modest
increases in Bcl-2 concentrations above endogenous levels
(Figure 3). To test this prediction, we expressed variable levels of
GFP-Bcl-2 in HeLa cells and then monitored tMOMP using a live-
cell reporter (IMS-RP, [23]) in cells exposed to 50 ng/ml TRAIL
plus low-dose cycloheximide. At wild-type levels of Bcl-2, all cells
died within 5 hr, but as GFP-Bcl-2 levels increased above 4610
5
molecules/cell (,13-fold above wild-type), a sudden transition was
observed in tMOMP such that cell death was blocked indefinitely
(Figure 7A). Between 2610
5 and 4610
5 Bcl-2 molecules/cell we
observed a region of variable fate, with a subset of cells undergoing
MOMP and others surviving (Figure 7A, gray shaded region). To
Figure 7. Overexpression of Bcl-2 in HeLa cells shows a region of variable fate before a threshold is reached where all cells survive.
(A–B) Scatter plots showing the relationship between tMOMP and total Bcl-2 amount as measured in HeLa cells treated with 50 ng/ml TRAIL and
2.5 mg/ml cycloheximide (left) or simulated in EARM1.3, sampling linearly in the exponent for GFP-Bcl-2 levels and from a joint distribution for Bax,
Bcl-2, Bid, caspase-3 and XIAP and independently for all other non-zero initial protein concentrations (right). Quantitative immunoblotting (Figure S5
in Text S1) and single-cell fluorescence quantification were combined to derive the absolute levels of GFP-Bcl-2 for each cell, to which the average
endogenous Bcl-2 amount (30,000 molecules/cell; experimentally unobservable) was added to convert the x-axis to units of total Bcl-2 molecules per
cell. Cells that did not undergo MOMP by 12 hr were assumed to have survived. (C) Boxplots of initial protein concentration distributions for surviving
(green) or dying (gray) simulated cells selected for having a range of total Bcl-2 expression where ,50% died (,53,000–57,000 molecules/cell). Box
edges show the 25
th and 75
th percentiles, notches show the 95% confidence interval for the median (horizontal line), and whiskers extend to the
most extreme data points that are not considered outliers. Asterisks indicate proteins for which the surviving and dying simulated cells show
significantly different medians for initial concentration (p,0.05), double asterisks mark the distributions for [Bax]0 which have the most significant
difference. (D) Bar graph showing the coefficients of variation (CV) obtained for model output distributions of tMOMP when using 3610
4 Bcl-2/cell as
the mean [Bcl-2]0 (striped bars; reproduced from Figure 4B), or when the average [Bcl-2]0 was changed to 6610
4 Bcl-2/cell (solid bars). As in Figure 4,
proteins were classified as affecting the pre-MOMP rate of initiator caspase activity (Rate; gray), the MOMP threshold (Threshold; purple) or post-
MOMP processes (Post-MOMP; green).
doi:10.1371/journal.pcbi.1002482.g007
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using correlated initial conditions and sampled GFP-Bcl-2 levels
over the experimentally observed range of 10
4 to 1.2610
6
molecules per cell. Simulations were run for 12 hr, well past the
time at which the last cells died in experiments; any simulated cells
that had not undergone MOMP by 12 hr were assumed to have
survived. As in real cells, we observed a region of variable fate at
intermediate levels of Bcl-2 (Figure 7B, gray shaded region)
although Bcl-2 levels bounding the region of variable fate were
,3–4-fold lower in simulations than in experiments, a discrepancy
we attribute either to error in the measurement of absolute protein
abundance or to imprecise model calibration. When we used
simulation to compare initial protein concentrations in cells that
are predicted to survive vs. cells that are predicted to die (within
the region of variable fate), we observed that [Bax]0 differed the
most: cells that died had higher [Bax]0 and those that survived had
lower [Bax]0 (Figure 7C, double asterisks). Thus, whereas multiple
proteins play a role in controlling variability in death time under
wild-type conditions (Figure 4B–C), under conditions of moderate
Bcl-2 over-expression, [Bax]0 becomes the primary regulator of
cell fate (Figure 7C).
Control over variability of time-to-death in a multi-
dimensional landscape
Given these findings, we asked whether simply doubling Bcl-2
levels would change which proteins were most influential in
controlling variability in tMOMP. Strikingly, simply doubling the
average initial Bcl-2 concentration from 3610
4 to 6610
4 proteins
per cell was sufficient to alter the sensitivity of tMOMP to variation in
the levels of other apoptosis regulators proteins. At 3610
4 Bcl-2/
cell, no single protein had a dominant effect on variability in tMOMP
(Figure 4B) whereas at 6610
4 Bcl-2/cell, Bax and Bcl-2 had nearly
three times greater impact than any other protein, and varying
either Bax or Bcl-2 yielded nearly as much variability in tMOMP as
did varying all proteins simultaneously (sampling independently;
Figure 7D). This demonstrates that protein over-expression (and
presumably also protein depletion) changes the relative impor-
tance of other proteins in control of tMOMP. We also note that
doubling [Bcl-2]0 significantly increased the variability of tMOMP:
CV increased from 0.25 to 0.36 (black bars in Figures 4B and 7D,
and Figure S12 in Text S1). Thus, the contribution made by
variation in the level of particular proteins to variability in
outcome is not necessarily a constant: contributions of individual
proteins can vary dramatically over biologically plausible concen-
tration ranges. Such contextual dependence of protein sensitivity
also shows how protein over-expression can be misleading with
respect to identifying factors that regulate a phenotype under
endogenous conditions.
To further explore this context sensitivity, we focused on the
joint control of tMOMP by three proteins that most influenced its
variability in the model: Bcl-2, Bax, and Bid (Figure 4B). We
changed [Bax]0 and [Bid]0 above and below default values in
discrete three and ten-fold steps, respectively (the magnitude of
these steps was chosen based on the sensitivity of tMOMP to the
initial protein concentrations when evaluated under baseline
conditions), while computing the relationship between tMOMP and
[Bcl-2]0. We observed that changing [Bax]0 shifted the tMOMP vs.
[Bcl-2]0 curves along the x-axis whereas increasing [Bid]0 shifted
the curves along the y-axis and also changed the sharpness of the
curves (Figure 8A). The net result was that changes in [Bax]0
affected the concentration of Bcl-2 at which cell fate switched from
death to survival, whereas changes in [Bid]0 affected the mean and
variance of tMOMP. The impact of natural variability in Bcl-2
expression (measured in HeLa cells; orange shading) on variance
in tMOMP was greater at lower Bax levels (Figure 8B). For cells with
normal [Bid]0, lowering [Bax]0 shifted the cells such that
endogenous variability in [Bcl-2]0 created a huge spread in death
time, with some cells surviving even at endogenous [Bcl-2]0
(Figure 8A–B, left). Taken together, these results demonstrate that
the sensitivity of tMOMP to Bcl-2 levels is itself sensitive to the levels
of two interacting proteins (a form of second-order sensitivity).
Discussion
In this paper we examine the impact of naturally occurring
variability in protein levels on variability in TRAIL-induced
apoptosis. Our approach builds on previous work showing that
variability in the timing and probability of death arises from cell-
to-cell differences in protein levels that exist prior to TRAIL
exposure and that this variability can therefore be modeled within
a deterministic framework [15]. We make use of four features of
apoptosis dynamics to explore the contributions made by
variability in regulatory molecules to variability in the timing
and efficiency of cell death. These dynamics were simulated by
sampling from either independent or joint distributions whose
variances were determined experimentally or estimated to
represent the range of endogenous protein expression. Model
parameters were not adjusted in this study to reproduce observed
variability in responses to TRAIL; rather our ability to reproduce
experimental data simply arose from substituting single values for
initial conditions with log-normal distributions centered on
previously determined EARM protein concentrations
[15,23,29,34]. Using sampling and feature-based sensitivity
analyses, we find that multiple upstream proteins control the
timing of death (tMOMP or tPARP) in HeLa cells, but that XIAP is the
primary determinant of the rate and extent of death (tswitch and
fPARP, respectively). We also find that co-variation in protein levels
reduces variability in death time, particularly when activator-
inhibitor pairs are assumed to co-vary positively (e.g. Bcl-2 and
Bax). Finally, we show through simulation and experiment that
HeLa cells reside near a region of extreme sensitivity to Bcl-2 such
that modest Bcl-2 over-expression causes cells to enter a region of
parameter space associated with variable fate in which the primary
determinants of phenotypic variability are quite different from
those pertaining to normal conditions.
Correlations in the levels of different proteins across a
population of single cells changes the apparent importance of
specific proteins in controlling cellular phenotypes. Simulations
based on measured correlations in protein concentrations appear
to better represent the biology of real cells. However, we have
found that such correlations can also have unexpected results
because correlations can mask the biochemical roles of specific
proteins. To date, we have only measured ten pairwise correlations
(creating a joint distribution for five protein species) but in real
cells, extrinsic noise will correlate all proteins to some degree
unless they are actively regulated otherwise [35]. Using Equation 2
(Box 2), it is straightforward to estimate the potential impact of
correlated protein expression (for pairs or larger sets of proteins) on
model output and to prioritize measurement of those correlations
with the greatest potential impact.
Under wild-type conditions, variability in the time at which a
cell dies arises from variability in the concentrations of multiple
regulatory molecules. Even perfect knowledge of the concentra-
tion of the model species that most strongly influences phenotype
is only partially predictive of time-to-death because variability in
other proteins makes a substantial contribution. In wild-type
HeLa cells, knowledge of the eight most sensitive proteins is
required to achieve a level of predictive ability (R
2,0.8) that can
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reaction corresponding to cleavage of the initiator caspase
reporter protein [15]. This reflects the fact that a dynamic
measurement reporting on a complex reaction has significantly
more ‘‘information content’’ than a series of static measure-
ments.
The ability of Bcl-2 to block apoptosis is well known [37,38,39]
but our analysis sheds light on the precise mapping between the
levels of Bcl-2 in individual cells and time of death. A relatively
modest increase in Bcl-2 concentration (6-fold to 13-fold over
endogenous Bcl-2 levels) causes cells to enter a region of parameter
space associated with variable fate; in this region, Bax becomes the
primary factor determining whether a cell lives or dies. A further
increase in Bcl-2 over-expression (.13-fold) causes MOMP to be
blocked indefinitely and corresponds approximately to the degree
of Bcl-2 over-expression found in leukemic cells [40]. We note that
in other cell types, this degree of over-expression might have no
effect due to compensatory changes in the levels of other proteins
in the apoptotic network. In Type I cells, for example, over-
expression of Bcl-2 does not block death because MOMP is not
needed to trigger apoptosis [41]. We have previously suggested
that tPARP in HeLa cells is primarily determined by proteins
controlling the rate of initiator caspase activation [15], but the
results in this paper suggest that in other cells (e.g. those with
slightly higher Bcl-2 levels than HeLa cells, Figure 7D), time-to-
death may be primarily determined by other proteins, such as
those that control the MOMP threshold. Whether the particular
sensitivity of HeLa cells to natural variation in Bcl-2 and Bax levels
confers a selective advantage or whether it is accidental cannot yet
be determined.
The context dependence of classical and feature-based sensitiv-
ities is obvious mathematically but it is generally under-
appreciated: sensitivity is not simply a function of network
topology but also of position in parameter space. We show that
‘‘context dependence’’ is relevant over the natural range of protein
concentrations found in populations of human cells. In HeLa cells,
for example, variation in the levels of six proteins contributes
roughly equally to variability in time of death under normal
conditions, but when Bcl-2 levels are raised just two fold, only two
proteins exert a significant impact. A clear implication is that we
cannot consider experiments in which proteins levels are altered
one at a time (by RNAi or over-expression) to represent univariate
explorations of regulatory mechanism. Instead, protein over-
expression and protein depletion shift cells in parameter space
such that different proteins are dominant in controlling phenotype
as compared to a wild-type context. This is true even if we
Figure 8. Variability in cell fate and time-to-death depends on the interplay between multiple factors. (A) Plots of tMOMP as a function of
Bcl-2 level for three levels of Bax (0.3X [Bax]0, left, 1X [Bax]0, center, and 3X [Bax]0, right) and Bid (0.1X [Bid]0, blue, 1X [Bid]0, green, and 10X [Bid]0, red).
Orange shading represents the 5
th and 95
th percentiles of the measured distribution of endogenous Bcl-2 in HeLa cells. (B) Histograms of the tMOMP
distributions in the range of endogenous Bcl-2 (indicated by the orange shading) for varying Bid and Bax levels. For panels A and B, initial
concentrations of Bcl-2 were sampled uniformly in the exponent between 10
2 to 10
7 molecules per cell and all other proteins concentrations were set
at their default mean values (Table S2 in Text S3).
doi:10.1371/journal.pcbi.1002482.g008
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and leave out the undoubtedly significant compensatory effects
that occur at the level of other cellular pathways. Thus, the
importance of specific proteins in a regulatory pathway is likely to
be mis-estimated based on univariate and qualitative assessment of
experimental perturbation; quantitative, system-level approaches
promise to be more accurate in this regard.
Non-genetic heterogeneity has recently emerged as an important
topic in a variety of fields and it has become increasingly clear that
cell-to-cell variability in protein expression is a key factor in a wide
range of cellular decisions [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15]. We
expect the approach described here for analyzing cell-to-cell
variability in receptor-mediated apoptosis to be generally useful in
the analysis of other signaling systems in which phenotypic
variability is observed. This is particularly true in those cases in
which pre-existing variation in protein levels is a dominating
influence and it is appropriate to use deterministic modeling
coupled to Monte-Carlo procedures for sampling parameter
distributions.
Methods
Cell culture and transfections
HeLa cells were maintained in DMEM (Mediatech, Inc)
supplemented with L-glutamine (Gibco), penicillin/streptomycin
(Gibco) and 10% fetal bovine serum (FBS, Mediatech, Inc).
FuGENE 6 (Roche) was used to transfect HeLa cells expressing
IMS-RP [23] with a pExchange vector (Stratagene) into which we
cloned a cDNA for EGFP-Bcl-2. Stable EGFP-Bcl-2 transfectants
were isolated by selecting withneomycin and sorted on a FACSAria
(BD Biosciences) to sample expression levels across a wide range.
Live-cell microscopy
HeLa cells expressing IMS-RP and GFP-Bcl-2 were plated in a
96-well glass bottom plate (Matrical). For all live-cell microscopy
experiments, cells were treated with 50 ng/ml Superkiller TRAIL
(Alexis Biochemicals) and 2.5 ug/ml cycloheximide (Sigma-
Aldrich) and imaged on a Nikon TE2000E at 206magnification
with frames every 5 min in a 37uC humidified chamber in phenol-
red free CO2-independent medium (Invitrogen) supplemented
with 1% FBS, L-Glutamine, and Penicillin/Streptomycin). GFP-
Bcl-2 fluorescence was quantified at t=0 (time of treatment) by
manually outlining the cell and measuring the average fluores-
cence intensity within the outline. MOMP was scored manually by
monitoring cytosolic translocation of IMS-RP. To convert the x-
axes in Figure 6A to proteins/cell, the average GFP fluorescence
intensity at t=0 was set equal to the average number of GFP-
tagged proteins per cell as measured by quantitative immunoblot-
ting (Figure S5 in Text S1).
Flow cytometry
Distributions of initial protein levels were measured in untreated
HeLa cells (fixed with 4% paraformaldehyde and permeabilized
with methanol) on a FACSCalibur (BD Biosciences). Antibodies
were carefully validated as described in Figures S6, S7 in Text S1
and the following antibodies were found to be suitable for
measurement of total protein levels: a-Bid (HPA000722, Atlas
Antibodies), a-Bax (MAB4601, Chemicon International), a-Bcl-2
(SC7382 and SC783, Santa Cruz Biotechnology), a-XIAP (610717,
BD Biosciences), a-caspase-3 (SC7272, Santa Cruz Biotechnology).
Correlations in protein levels were measured by combining pairs of
antibodies generated in different species or pairing fluorophore-
conjugated version of the primary antibodies listed above (a-
caspase-3-AF488, a-Bax-PE, a-XIAP-AF647). Cells were gated in
both forward scatter and side scatter to select a population of cells of
similar size and the data analyzed in MatLab (Mathworks).
Modeling
Simulations were run in Jacobian (RESgroup) using the
EARM1.3 ordinary differential equation model. EARM1.3 is an
extension of the original EARM1.1 [29], modified to include
general protein synthesis and degradation as described previously
[15]. This model had been manually calibrated to represent the
response of a single HeLa cell to TRAIL treatment [18]. Lists of
reactions, initial protein concentration and parameter values are
included in Tables S1, S2, S3, S4 in Text S3.
When sets of simulations called for sampling from distributions
of initial protein levels, we used a custom Perl script to generate
series of random numbers that were sampled from a multivariate
normal distribution with specified variances and co-variances (see
Tables S2 and S3 in Text S3). These number series were then
transformed to achieve the final log-normally distributed series
with appropriate means and coefficients of variation.
To calculate feature sensitivities numerically, series of simula-
tion pairs were run for each protein by sampling its initial
concentration uniformly in the exponent for values between 10
2 to
10
7 proteins per cell and then running simulations using 100% and
101% of this value, setting all other initial protein concentrations
and rate constants at their default value. Sensitivities were then
calculated using:
Lq
Llog10k
&
q101
log10k101
{
q100
log10k100
where k100 and k101 are the values of the sampled initial protein
concentration for the simulation pair (100% and 101%, respec-
tively) and similarly q100 and q101 are the values of feature q using
100% and 101% of the sampled initial protein concentration,
respectively.
Supporting Information
Text S1 Supporting experimental and computational
results. This text contains Figures S1, S2, S3, S4, S5, S6, S7, S8,
S9, S10, S11, S12, a compilation of additional experimental and
computational results.
(PDF)
Text S2 Derivation of equations. This text contains
explanatory notes on the relationships between feature-based
and conventional sensitivities and on how sensitivities propagate
variance in initial protein concentration to variance in pathway
outputs as well as the derivations of Box 1 Equation 1 and Box 2
Equation 2.
(PDF)
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S1, S2, S3, S4 which list model reactions (Table S1), initial protein
concentrations (averages and coefficients of variation; Table S2),
protein covariances (Table S3) and parameter values (Table S4)
used in EARM1.3.
(PDF)
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